Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
in response to MagBeach's message

I think the CF Litigation could well be TPL's attempt to support that the CF portfolio is worth more than PTSC has argued in their court filings, thus reducing TPL's exposure in the event there are settlements in the future where TPL has to reimburse PTSC for comingled discounted MMP licenses that have been signed in the past.

See l2007s post regarding the Apple license for example. If TPL assigned 5% to MMP and 50% to CF, then getting a settlement with an infringer on CF that is more in line with what they charged Apple would help TPL argue that the percentage values applied were accurate.

Please login to post a reply
lambertslunatics
City
Rank
President
Activity Points
22114
Rating
Your Rating
Date Joined
06/18/2007
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post